Patheon Inc  

(Public, TSE:PTI)   Watch this stock  
Find more results for PTI
- Close
TSE data delayed by 15 mins - Disclaimer
Currency in
Range     -
52 week 3.57 - 10.35
Open     -
Vol / Avg. 0.00/238,083.00
Mkt cap     -
P/E     -
Div/yield     -
EPS -0.29
Shares     -
Beta     -
Inst. own     -

Key stats and ratios

Q4 (Oct '13) 2013
Net profit margin 3.86% -3.49%
Operating margin 7.72% 3.31%
EBITD margin - 12.02%
Return on average assets 4.18% -3.92%
Return on average equity 37.39% -28.48%
Employees 5,900 -
CDP Score - -


Suite 200, 4721 Emperor Blvd.,
DURHAM, NC 27703-8580
United States - Map
+1-919-2263200 (Phone)

Website links


Patheon Inc. is a provider of commercial manufacturing outsourcing services (CMO) and outsourced pharmaceutical development services (PDS) to the global pharmaceutical industry. The Company offers a range of services throughout the lifecycle of a pharmaceutical molecule, from early development, through late development to commercial manufacturing, including lifecycle management services. The Company operates in two segments: CMO and PDS. The Company�s CMO business focuses on prescription products in a range of solid and sterile dosage forms. Its PDS business provides a range of development services, including finished dosage formulation across approximately 40 dosage forms, early development services, analytical services, formulation expertise and life cycle management. On March 11, 2014, JLL/Delta Canada Inc., an indirect subsidiary of JLL/Delta Patheon Holdings, L.P., and the Company were amalgamated.